FivepHusion announces successful completion of Phase 1 component of paediatric brain cancer trial

June 24, 2025 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

FivepHusion has announced the successful completion of the Phase 1 component of the Deflexifol at Relapse Trial, supported by the Kids with Cancer Foundation, an Australian-led study of a new brain cancer treatment for children. …

Subscribe now to continue reading.

Latest Video

Time to save the government from itself and its own bad habits on this program
November 17, 2025 - Latest News
We know they're planning something on these issues, because they told us
November 18, 2025 - Latest News
The need to honour a strong history while ensuring the future is guided by the 'good guys'
November 17, 2025 - Latest News
BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia
November 17, 2025 - Latest News
New national incubator aims to supercharge Australian vaccine innovation
November 17, 2025 - Latest News

FivepHusion announces successful completion of Phase 1 component of paediatric brain cancer trial

This is a preview of subscriber content

Latest Video

Most Read

Time to save the government from itself and its own bad habits on this program

We know they're planning something on these issues, because they told us

The need to honour a strong history while ensuring the future is guided by the 'good guys'

BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia

New national incubator aims to supercharge Australian vaccine innovation

New Stories

Dimerix Phase 3 kidney trial clears seventh safety review

Prescient secures EU orphan status for PTX-100 for cutaneous T-cell lymphomas

BCAL advances early cancer detection portfolio as Australian launch looms

Is this disconnect so entrenched we can no longer recognise the presence of a problem?

Minister managing the 'double-whammy' of participant and plan growth

Tryp advances psilocin trial for binge eating disorder as second patient enrolled

Nyrada advances toward Phase 2a trial of cardioprotective candidate

Sign In

FivepHusion announces successful completion of Phase 1 component of paediatric brain cancer trial

This is a preview of subscriber content

Latest Video

Most Read

Time to save the government from itself and its own bad habits on this program

We know they're planning something on these issues, because they told us

The need to honour a strong history while ensuring the future is guided by the 'good guys'

BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia

New national incubator aims to supercharge Australian vaccine innovation

Follow Us

New Stories

Dimerix Phase 3 kidney trial clears seventh safety review

Prescient secures EU orphan status for PTX-100 for cutaneous T-cell lymphomas

BCAL advances early cancer detection portfolio as Australian launch looms

Is this disconnect so entrenched we can no longer recognise the presence of a problem?

Minister managing the 'double-whammy' of participant and plan growth

Tryp advances psilocin trial for binge eating disorder as second patient enrolled

Nyrada advances toward Phase 2a trial of cardioprotective candidate